Table 2 Summary of risk of hepatitis A to travelers and typical vaccine recommendations by Global Burden of Disease (GBD) Study region.
From: Challenges to mapping the health risk of hepatitis A virus infection
Region | Risk to travelers from low-risk areas[9] | Typical Vaccine Recommendation | |
|---|---|---|---|
| Â | Â | for residents of region[6] | |
South sub-Saharan Africa | Very High | Recommended | Not recommended |
West sub-Saharan Africa | Very High | Recommended | Not recommended |
South Asia | Very High | Recommended | Not recommended |
Central sub-Saharan Africa | Very High | Recommended | Not recommended |
East sub-Saharan Africa | Very High | Recommended | Not recommended |
Central Latin America | High | Recommended | Targeted |
Andean Latin America | High | Recommended | Targeted |
Central Asia | High | Recommended | Targeted |
Southern Latin America | High | Recommended | Targeted |
Tropical Latin America | High | Recommended | Targeted |
North Africa/Middle East | High | Recommended | Targeted |
Oceania | High | Recommended | Targeted |
Caribbean | Intermediate | Recommended | Universal |
Southeast Asia | Intermediate | Recommended | Universal |
Eastern Europe | Intermediate | Recommended | Universal |
East Asia | Intermediate | Recommended | Universal |
High-income Asia Pacific | Low | Not recommended | Targeted |
Australasia | Low | Not recommended | Targeted |
Western Europe | Low | Not recommended | Targeted |
High-income North America | Low | Not recommended | Targeted |